Merck has announced plans to spin off its Biosimilars, Women’s Health and Legacy Brands units into a separate company.
Merck & Co has announced plans to spin off its Biosimilars, Women’s Health and Legacy Brands units into a “new, yet-to-be-named, independent, publicly-traded company.”
The firm, known as Merck, Sharp & Dohme or MSD outside the US and Canada, said the spinoff – which...
The UK government has said it will invest almost £30m ($40.4m) in AI technologies to modernize the NHS and reduce wait times – but for the medtech sector, the devil will be in the details.
The UK government has said it will invest almost £30m ($40.4m) in AI technologies to modernize the NHS and reduce wait times – but for the medtech sector, the devil will be in the details.
Mounjaro, Eliquis, and Darzalex buck the Q1 trend to make gains
The UK government has said it will invest almost £30m ($40.4m) in AI technologies to modernize the NHS and reduce wait times – but for the medtech sector, the devil will be in the details.
The UK government has said it will invest almost £30m ($40.4m) in AI technologies to modernize the NHS and reduce wait times – but for the medtech sector, the devil will be in the details.
Mounjaro, Eliquis, and Darzalex buck the Q1 trend to make gains
